Medication Brand Names Beginning with ‘N’, Page 21

Page 21 of 217 « First Page « … 5 10 15 … 19 20 21 22 23 … 30 35 40 45 50 … » Last Page »

NAGLAZYME (Galsulfase)

NAGLAZYME is indicated for patients with Mucopolysaccharidosis VI (MPS VI. Maroteaux-Lamy syndrome). NAGLAZYME has been shown to improve walking and stair-climbing capacity. NAGLAZYME is…

BioMarin Pharmaceutical Inc.14 April 2020

NALBUPHINE HCI

Nalbuphine Hydrochloride Injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Nalbuphine…

HF Acquisition Co LLC, DBA HealthFirst22 February 2020

Nalbuphine Hydrochloride

Nalbuphine Hydrochloride Injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Nalbuphine…

Medical Purchasing Solutions, LLC24 January 2020

Nalbuphine Hydrochloride

Nalbuphine Hydrochloride Injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Nalbuphine…

McKesson Corporation dba SKY Packaging25 January 2020

Nalbuphine Hydrochloride

Nalbuphine Hydrochloride Injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Nalbuphine…

Hospira, Inc.26 February 2020

Page 21 of 217 « First Page « … 5 10 15 … 19 20 21 22 23 … 30 35 40 45 50 … » Last Page »

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.